Thomas Jefferson University

Madhukar Thakur

TitleProfessor
InstitutionThomas Jefferson University
DepartmentRadiology
Address1020 Locust St.
Philadelphia PA 19107
Phone215-503-7874
vCardDownload vCard

    Collapse Biography 
    Collapse awards and honors
    2009John McAfee medal , International Soc. of radiolabeled Blood elements
    2009Image of the Year Award, Seiman’s Medical Incorporation’s
    2008Benedict Cassen Award, Society of Nuclear Medicine and ERF
    2001Berson-Yalow Award, Greater New York and New England Chapter of the Society of Nuclear Medicine
    2000Georg de Hevesy Award, Society of Nuclear Medicine
    1998Lifetime Achievement Award, Indo-American Society of Nuclear Medicine
    1995Vikram Sarabhai Oration Award, Society of Nuclear Medicine-India
    1992Paul Aebersold award, Society of Nuclear Medicine
    1980Maurice Chamberland Award, American Chemical Society

    Collapse Overview 
    Collapse overview
    Nuclear Medicine
    Magnetic Resonance Imaging
    Computed Tomography
    Optical Imaging
    Radiopharmaceutical and Molecular Research

    Nuclear Medicine
    Magnetic Resonance Imaging

    Website: https://sites.google.com/site/mathewthakur/



    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ghagane SC, Rangrez S, Nerli RB, Thakur ML, Gomella LG. Use of TP4303 to identify prostate cancer cells in voided urine samples. Can J Urol. 2024 Jun; 31(3):11892-11896. PMID: 38912942.
      Citations:    
    2. Nerli R, Kalloli M, Rangrez S, Ghagane SC, Vinchurkar K, Chandra S, Thakur ML. Diagnosis of Oral Cancers by Targeting VPAC Receptors: Preliminary Report. Asian Pac J Cancer Prev. 2023 05 01; 24(5):1711-1715. PMID: 37247292.
      Citations:    
    3. Nerli RB, Ghagane SC, Rangrez SS, Chandra S, Thakur ML, Gomella L. Author Reply Re: Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol 2021;37:345-9. Indian J Urol. 2022 Jan-Mar; 38(1):78-79. PMID: 35136304.
      Citations:    
    4. Nerli RB, Ghagane SC, Bidi SR, Thakur ML, Gomella L. Voided urine test to diagnose prostate cancer: Preliminary report. Cytojournal. 2021; 18:26. PMID: 34754324.
      Citations:    
    5. Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol. 2021 Oct-Dec; 37(4):345-349. PMID: 34759527.
      Citations:    
    6. Krishn SR, Singh A, Bowler N, Duffy AN, Friedman A, Fedele C, Kurtoglu S, Tripathi SK, Wang K, Hawkins A, Sayeed A, Goswami CP, Thakur ML, Iozzo RV, Peiper SC, Kelly WK, Languino LR. Prostate cancer sheds the avß3 integrin in vivo through exosomes. Matrix Biol. 2018 Aug 08. PMID: 30098419.
      Citations:    
    7. Lisanti S, Tavecchio M, Chae YC, Liu Q, Brice AK, Thakur ML, Languino LR, Altieri DC. Deletion of the Mitochondrial Chaperone TRAP-1 Uncovers Global Reprogramming of Metabolic Networks. Cell Rep. 2014 Aug 7; 8(3):671-7. PMID: 25088416.
      Citations:    
    8. Gomella LG, Solomides C, Trabulsi EJ, Chen C-P, Tripathi SK, Wickstrom E, Zhang K, Thakur ML. Vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide receptor 1 (VPAC1 targeted detection of genitourinary cancer: a urinary assay. 2014.
    9. Wickstrom E, Chen C-P, Paudyal B, Wampole ME, Zhang K, Paudyal B, Wang A, Tripathi SK, Kumar P, Lu B, Thakur ML. American Association for Cancer Research Conference on RAS Oncogenes: From Biology to Therapy. Hypoxanthine wobble base multimutant KRAS2 mRNA PET imaging agent in G12D mice. 2014.
    10. Zaorsky NG, Yamoah K, Thakur ML, Trabulsi EJ, Showalter TN, Hurwitz MD, Dicker AP, Den RB. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. Future Oncol. 2014 Feb; 10(3):457-74. PMID: 24559451.
      Citations:    
    11. Thakur ML. A. Dicker. PET: The Future Of Screening, Diagnosis and Staging, In Current Multidisciplinary Oncology. 2014.
    12. Tripathi SK, Trabulsi E, Kim S, Intenzo C, McCue P, Mashayekh A, Gandhe A, Wickstrom E, Gomella L, Thakur ML. J Nucl Med. VPAC1 targeted PET imaging of prostate cancer. 2014.
    13. Kumar P, Trapathi SK, Cheng C, Paudyal B, Mehta N, Wickstrom E, Thakur ML. J Nucl Med. Preparation and preliminary evaluation of Ga-68 NODAGA-peptide for targeting VPAC1 receptor. 2014.
    14. Tripathi SK, Trabulsi E, Kumar P, Birbe R, Cotzia P, McCue P, Solomides C, Gomella L, Thakur ML. Imaging bladder cancer: correlation with histopathologic findings. 2014.
    15. Thakur ML. Radiolabeled biomolecules for specific imaging of cancers of the breast, prostate and lungs. JRNC. 2014.
    16. Wampole ME, Kairys JC, Mitchell EP, Ankeny ML, Thakur ML, Wickstrom E. Consistent surgeon evaluations of three-dimensional rendering of PET/CT scans of the abdomen of a patient with a ductal pancreatic mass. PLoS One. 2013; 9(8).
    17. Wampole ME, Kairys JC, Mitchell EP, Ankeny ML, Thakur ML, Wickstrom E. Consistent Surgeon Evaluations of Three-Dimensional Rendering of PET/CT Scans of the Abdomen of a Patient with a Ductal Pancreatic Mass. PLoS One. 2013; 8(9):e75237. PMID: 24086475.
      Citations:    
    18. Paudyal B, Zhang K, Chen CP, Wampole ME, Mehta N, Mitchell EP, Gray BD, Mattis JA, Pak KY, Thakur ML, Wickstrom E. Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA. Nucl Med Biol. 2013 Nov; 40(8):994-9. PMID: 24074944.
      Citations:    
    19. Sanders JM, Wampole ME, Chen CP, Sethi D, Singh A, Dupradeau FY, Wang F, Gray BD, Thakur ML, Wickstrom E. Effects of Hypoxanthine Substitution in Peptide Nucleic Acids Targeting KRAS2 Oncogenic mRNA Molecules: Theory and Experiment. J Phys Chem B. 2013 Oct 3; 117(39):11584-95. PMID: 23972113.
      Citations:    
    20. Thakur ML, Zhang K, Berger A, Cavanaugh B, Kim S, Channappa C, Frangos AJ, Wickstrom E, Intenzo CM. VPAC1 Receptors for Imaging Breast Cancer: A Feasibility Study. J Nucl Med. 2013 Jul; 54(7):1019-25. PMID: 23651947.
      Citations:    
    21. Sonar MV, Wampole ME, Jin Y-Y, Thakur ML, Wickstrom E. Thiazole orange PNA-peptides as intercalative fluorescence imaging agents to detect hybridization with KRAS2 mRNA. 2013.
    22. Sanders JM, Wampole ME, Thakur ML, Wickstrom E. Molecular determinants of epidermal growth factor binding: a molecular dynamics study. PLoS One. 2013; 8(1):e54136. PMID: 23382875.
      Citations:    
    23. Paudyal B, Zhang K, Chen CP, Wampole ME, Mehta N, Mitchell EP, Gray BD, Mattis JA, Pak KY, Thakur ML, Wickstrom E. Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA. Nucl. Med. Biol. 2013; 8(40):994-999.
    24. Zaorsky NG, Yamoah K, Thakur ML, Trabulsi EJ, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Imaging techniques in the detection of recurrent prostate cancer: current status and future direction. Future Oncology. 2013.
    25. Thakur ML, Zhang K, Berger A, Cavanaugh B, Kim S, Channappa C, Frangos AJ, Wickstrom E, Intenzo CM. VPAC1 Receptors for Imaging Breast Cancer: A Feasibility Study. Journal of Nuclear Medicine. 2013; (54):1019-1025.
    26. Tripathi SK, Zhang K, Birbe R, Cotzia P, McCue PA, Solomides C, Gomella LG, Trabulsi EJ, Thakur ML. Eur J Nucl Med Mol Imaging. Detecting genitourinary cancer ex vivo: correlation with histopathologic findings. 2013; (40):179.
    27. Wickstrom E, Chen CP, Paudyal B, Wampole ME, Zhang K, Wang A, Lu B, Thakur ML. American Association for Cancer Research. Mutant KRAS2 mRNA, PET imaging in spontaneous transgenic lung cancers. 2013.
    28. Tripathi SK, Zhang K, Paudyal B, Mehta NA, Wang Y Wampole ME, Wickstrom E, Lu B. Imaging of KRAS2-activated early onset lung cancer in transgenic mice. 2013.
    29. Thakur ML, Zhang K, Tripathi SK, Solomides C, Channappa C, Chen CP, Wickstrom E, Trabulsi EJ, Gomella LG. J Nucl Med. Gene based detection of genitourinary cancer cells. 2013; (54):19.
    30. Sonar MV, Wampole ME, Sanders JM, Thakur ML, Wickstrom E. Design and synthesis of thiazole orange PNA,-peptides as fluorescence imaging agents for KRAS2 mRNA. 2013.
    31. Thakur ML, Zhang K, Tripathi SK, Channappa C, McCue PA, Trabulsi EJ. Ex vivo evaluation of Cu-64-TP3805 for imaging prostate cancer. 2013.
    32. Sanders JM, Wampole ME, Chen C-P, Sethi D, Singh A, Dupradeau FY, Wang F, Gray BD, Thakur ML, Wickstrom E. Effects of hypoxanthine substitution in peptide nucleic acids targeting KRAS2 oncogenic mRNA molecules: theory and experiment. Journal of Physical Chemistry. 2013; 39(117):11584-11595.
    33. Thakur ML. Kit for tumor imaging. 2013.
    34. Thakur ML. Method for detecting circulating tumor cells in biological fluids. 2013.
    35. Zaorsky NG, Yamoah K, Thakur ML, Trabulsi EJ, Showalter TN, Hurwitz MD, Dicker AP, Den RB. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. Future Oncol. 2013; 3(10):457-474.
    36. Thakur ML, Zhang K, Paudyal B, Devakumar D, Covarrubias MY, Chen CP, Cheng C, Gray BD, Wickstrom E, Pak KY. Targeting apoptosis for optical imaging of infection. Mol Imaging Biol. 2012 Apr; 14(2):163-71. PMID: 21538153.
      Citations:    
    37. Sethi D, Chen CP, Jing RY, Thakur ML, Wickstrom E. Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells. Bioconjug Chem. 2012 Feb 15; 23(2):158-63. PMID: 22239616.
      Citations:    
    38. Sethi D, Thakur ML, Wickstrom E. Receptor-specific peptides for targeting of liposomal, polymeric, and dendrimeric nanoparticles in cancer diagnosis and therapy. Molecular Imaging. 2012; (1):3-11.
    39. Thakur ML, Zhang K, Paudyal B, Devakumar D, Covarrubias MY, Cheng C, Gray BD, Wickstrom E and Pak KY. Targeting apoptosis for optical imaging of infection. Mol Imaging Biol. 2012; (14):163-171.
    40. Chen CP, Sethi D, Thakur ML, Wickstrom E. Hypoxanthine-containing peptide nucleic acid hybridization agents to detect multiple KRAS2 mutations. 2012.
    41. Goldberg BB, Merton DA, Liu JB, Forsberg F, Zhang K, Thakur M, Schulz S, Schanche R, Murphy GF, Waldman SA. Contrast-enhanced ultrasound imaging of sentinel lymph nodes after peritumoral administration of Sonazoid in a melanoma tumor animal model. J Ultrasound Med. 2011 Apr; 30(4):441-53. PMID: 21460143.
      Citations:    
    42. Wickstrom E, Chen CP, Devadhas D, Wampole M, Jin YY, Sanders JM, Kairys JC, Ankeny ML, Hu R, Barner KE, Steiner KV, Thakur ML. Three dimensional projection environment for molecular design and surgical simulation. Stud Health Technol Inform. 2011; 163:691-5. PMID: 21335882.
      Citations:    
    43. Opitz AW, Wickstrom E, Thakur ML, Wagner NJ. Physiologically based pharmacokinetics of molecular imaging nanoparticles for mRNA detection determined in tumor-bearing mice. Oligonucleotides. 2010 Jun; 20(3):117-25. PMID: 20406142.
      Citations:    
    44. Amirkhanov NV, Zhang K, Aruva MR, Thakur ML, Wickstrom E. Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [(111)In]DOTA(n)-poly(diamidopropanoyl)(m)-KRAS2 PNA-D(Cys-Ser-Lys-Cys) nanoparticles. Bioconjug Chem. 2010 Apr 21; 21(4):731-40. PMID: 20232877.
      Citations:    
    45. Wickstrom E, Thakur ML. Breast Cancer Risk Reduction and Early Detection, DOI 10.1007/978-0-387-87583-5_9. Genetic and Molecular Approaches to Imaging Breast Cancer. 2010; 163-182.
    46. Thakur ML, Devadhas D, Zhang K, Pestell RG, Wang C, McCue P, Wickstrom E. Imaging spontaneous MMTVneu transgenic murine mammary tumors: targeting metabolic activity versus genetic products. J Nucl Med. 2010 Jan; 51(1):106-11. PMID: 20008985.
      Citations:    
    47. Penn DL, Kim C, Zhang K, Mukherjee A, Devakumar D, Jungkind D, Thakur ML. Apoptotic abscess imaging with 99mTc-HYNIC-rh-Annexin-V. Nucl Med Biol. 2010 Jan; 37(1):29-34. PMID: 20122665.
      Citations:    
    48. Thakur ML. Genomic biomarkers for molecular imaging: predicting the future. Semin Nucl Med. 2009 Jul; 39(4):236-46. PMID: 19497401.
      Citations:    
    49. Mukherjee A, Wickstrom E, Thakur ML. Imaging oncogene expression. Eur J Radiol. 2009 May; 70(2):265-73. PMID: 19264436.
      Citations:    
    50. Mukherjee A, Thakur ML. ISBN: 978-1-60692-447-1. Role of Molecular Biology in Molecular Imaging. 2009; 187-217.
    51. Amirkhanov NV, Dimitrov I, Opitz AW, Zhang K, Lackey JP, Cardi CA, Lai S, Wagner NJ, Thakur ML, Wickstrom E. Design of (Gd-DO3A)n-polydiamidopropanoyl-peptide nucleic acid-D(Cys-Ser-Lys-Cys) magnetic resonance contrast agents. Biopolymers. 2008 Dec; 89(12):1061-76. PMID: 18680101.
      Citations:    
    52. Zhang K, Aruva MR, Shanthly N, Cardi CA, Rattan S, Patel C, Kim C, McCue PA, Wickstrom E, Thakur ML. PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer. J Nucl Med. 2008 Jan; 49(1):112-21. PMID: 18077536.
      Citations:    
    53. Tian X, Aruva MR, Zhang K, Shanthly N, Cardi CA, Thakur ML, Wickstrom E. PET imaging of CCND1 mRNA in human MCF7 estrogen receptor positive breast cancer xenografts with oncogene-specific [64Cu]chelator-peptide nucleic acid-IGF1 analog radiohybridization probes. J Nucl Med. 2007 Oct; 48(10):1699-707. PMID: 17909257.
      Citations:    
    54. Zhang K, Aruva MR, Shanthly N, Cardi CA, Patel CA, Rattan S, Cesarone G, Wickstrom E, Thakur ML. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation. Regul Pept. 2007 Dec 4; 144(1-3):91-100. PMID: 17727979.
      Citations:    
    55. Chakrabarti A, Zhang K, Aruva MR, Cardi CA, Opitz AW, Wagner NJ, Thakur ML, Wickstrom E. Radiohybridization PET imaging of KRAS G12D mRNA expression in human pancreas cancer xenografts with [(64)Cu]DO3A-peptide nucleic acid-peptide nanoparticles. Cancer Biol Ther. 2007 Jun; 6(6):948-56. PMID: 17611392.
      Citations:    
    56. Tian X, Chakrabarti A, Amirkhanov N, Aruva MR, Zhang K, Cardi CA, Lai S, Thakur ML, Wickstrom E. Receptor-mediated internalization of chelator-PNA-peptide hybridization probes for radioimaging or magnetic resonance imaging of oncogene mRNAs in tumours. Biochem Soc Trans. 2007 Feb; 35(Pt 1):72-6. PMID: 17233604.
      Citations:    
    57. Nylla Shanthly, Zhang K, Mohan R. Aruva, Christopher Kim, Thakur ML. D.K. Hazra. Radiolabeled peptides: approaches to diagnosis and therapy. 2007.
    58. Shanthly N, Aruva MR, Zhang K, Mathew B, Thakur ML. 99mTc-Fanolesomab: affinity, pharmacokinetics and preliminary evaluation. Q J Nucl Med Mol Imaging. 2006 Jun; 50(2):104-12. PMID: 16770300.
      Citations:    
    59. Wickstrom E, Thakur ML. Imaging cancer gene activity in patients from outside the body. Biotechnol Healthc. 2006 Feb; 3(1):45-8. PMID: 23423635.
      Citations:    
    60. Nylla Shanthly, Thakur ML. Application of Radiotracers in Chemical, Environmental and Biological Sciences. Radionuclides in Medical application. 2006.
    61. Tian X, Chakrabarti A, Amirkhanov NV, Aruva MR, Zhang K, Mathew B, Cardi C, Qin W, Sauter ER, Thakur ML, Wickstrom E. External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras. Ann N Y Acad Sci. 2005 Nov; 1059:106-44. PMID: 16382049.
      Citations:    
    62. Thakur ML, Lentle BC. Joint SNM/RSNA Molecular Imaging Summit Statement. J Nucl Med. 2005 Sep; 46(9):11N-13N, 42N. PMID: 16211779.
      Citations:    
    63. Thakur ML. PACAP Compositions and methods for tumor imaging and therapy. 2005.
    64. Wickstrom Eric, Thakur Mathew, Sauter Edward. Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules. Receptor-Specific Targeting with Complementary Peptide Nucleic Acids Conjugated to Peptide Analogs and Radionuclides. 2005.
    65. Wickstrom Eric, Xiaobing Tian, Amirkhanov N, Chakraborti Atis, Aruva MR, Rao PS,Qin Wenyi, Zhu Weizhu, Sauter ER, Thakur ML. Philips Ian (ed): Antisense Therapeutics. Radionuclide Peptide Nucleic Acid in Diagnosis and Treatment of Pancreatic Cancer. 2005.
    66. Aruva MR, Tian X, Zhang B, Shanthly N, Cardi C, Wickstrom E, and Thakur ML. Int. Symposium on Trends in Radiopharmaceuticals. Imaging Oncogene Expression in Breast Cancer with Receptor Specific Peptides and Peptide Nucleic Acids. 2005; 19-20.
    67. Tian X, Aruva MR, Wolfe HR, Qin W, Sauter ER, Thakur ML, Waldman SA, Wickstrom E. Tumor-targeting peptide-PNA-peptide chimeras for imaging overexpressed oncogene mRNAs. Nucleosides Nucleotides Nucleic Acids. 2005; 24(5-7):1085-91. PMID: 16248097.
      Citations:    
    68. Chakrabarti A, Aruva MR, Sajankila SP, Thakur ML, Wickstrom E. Synthesis of novel peptide nucleic acid-peptide chimera for non-invasive imaging of cancer. Nucleosides Nucleotides Nucleic Acids. 2005; 24(5-7):409-14. PMID: 16247960.
      Citations:    
    69. Wickstrom E, Tian X, Amirkhanov NV, Chakrabarti A, Aruva MR, Rao PS, Qin W, Zhu W, Sauter ER, Thakur ML. Radionuclide-peptide nucleic acid in diagnosis and treatment of pancreatic cancer. Methods Mol Med. 2005; 106:135-91. PMID: 15375316.
      Citations:    
    70. Weiner RE, Thakur ML. Radiolabeled peptides in oncology: role in diagnosis and treatment. BioDrugs. 2005; 19(3):145-63. PMID: 15984900.
      Citations:    
    71. Tian X, Aruva MR, Qin W, Zhu W, Sauter ER, Thakur ML, Wickstrom E. Noninvasive molecular imaging of MYC mRNA expression in human breast cancer xenografts with a [99mTc]peptide-peptide nucleic acid-peptide chimera. Bioconjug Chem. 2005 Jan-Feb; 16(1):70-9. PMID: 15656577.
      Citations:    
    72. Tian X, Aruva MR, Qin W, Zhu W, Duffy KT, Sauter ER, Thakur ML, Wickstrom E. External imaging of CCND1 cancer gene activity in experimental human breast cancer xenografts with 99mTc-peptide-peptide nucleic acid-peptide chimeras. J Nucl Med. 2004 Dec; 45(12):2070-82. PMID: 15585484.
      Citations:    
    73. Thakur ML, Aruva MR, Gariepy J, Acton P, Rattan S, Prasad S, Wickstrom E, Alavi A. PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog. J Nucl Med. 2004 Aug; 45(8):1381-9. PMID: 15299065.
      Citations:    
    74. Weiner RE, Thakur ML. Van der lely AJ (ed): Action of Somatostatin. Radiolabeled peptides in oncology. 2004.
    75. Wickstrom E, Thakur ML, Sauter ER. Letters in Peptide. Receptor-specific targeting with complementary peptide nucleic acids conjugated to peptide analogs and radionuclides. 2004; 191-214.
    76. Thakur ML. Imaging with Tc-99m labeled fibrin-a-chain peptide. 2004.
    77. Thakur ML. Lipid soluble radioactive active chelates for tumor therapy. 2004.
    78. Tian X, Aruva MR, Rao PS, Qin W, Read P, Sauter ER, Thakur ML, Wickstrom E. Imaging oncogene expression. Ann N Y Acad Sci. 2003 Dec; 1002:165-88. PMID: 14751834.
      Citations:    
    79. Rao PS, Tian X, Qin W, Aruva MR, Sauter ER, Thakur ML, Wickstrom E. 99mTc-peptide-peptide nucleic acid probes for imaging oncogene mRNAs in tumours. Nucl Med Commun. 2003 Aug; 24(8):857-63. PMID: 12869817.
      Citations:    
    80. Weiner RE, Thakur ML. Sandler M, Coleman RE (ed): Diagnostic Nuclear Medicine. Radiopharmaceuticals. 2003.
    81. Weiner RE, Thakur ML. Welch MJ, Redvanly CS (ed). Handbook of Radiopharmaceuticals. Chemistry of Gallium and Indium Radiopharmaceuticals. 2003.
    82. Thakur ML. Signore A, Liberatore M, Scopinaro F (ed). Nuclear Medicine in the Management of Inflammatory and Infectious Diseases. The use of radiolabeled monoclonal antibodies in inflammatory bowel diseases. 2003.
    83. Tian Xiaobing, Aruva MR, Rao PS, Qin Wenyi, Read Paul, Sauter ER, Thakur ML, Wickstrom Eric. Ann NY Acad. Sci. Imaging Oncogene Expression. 2003; 165-188.
    84. Weiner RE, Thakur ML. Radiolabeled peptides in the diagnosis and therapy of oncological diseases. Appl Radiat Isot. 2002 Nov; 57(5):749-63. PMID: 12433051.
      Citations:    
    85. Thakur ML. Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy. 2002.
    86. Weiner RE, Thakur ML. Radiolabeled peptides in diagnosis and therapy. Semin Nucl Med. 2001 Oct; 31(4):296-311. PMID: 11710772.
      Citations:    
    87. Krishnamurthy GT, Krishnamurthy S, Thakur ML, McAfee JG. Gopal Subramanian and the Tc-99m bone scan: a continuing benefactor. Semin Nucl Med. 2001 Oct; 31(4):258-9. PMID: 11710768.
      Citations:    
    88. Rao PS, Thakur ML, Pallela V, Patti R, Reddy K, Li H, Sharma S, Pham HL, Diggles L, Minami C, Marcus CS. 99mTc labeled VIP analog: evaluation for imaging colorectal cancer. Nucl Med Biol. 2001 May; 28(4):445-50. PMID: 11395318.
      Citations:    
    89. Thakur ML, Marcus CS, Kipper SL, Ahdoot R, Diggles L, Pham HL, Minami C. Imaging infection with LeuTech. Nucl Med Commun. 2001 May; 22(5):513-9. PMID: 11388572.
      Citations:    
    90. Rao PS, Pallela VR, Vassileva-Belnikolovska D, Jungkind D, Thakur ML. A receptor-specific peptide for imaging infection and inflammation. Nucl Med Commun. 2000 Nov; 21(11):1063-70. PMID: 11192713.
      Citations:    
    91. Thakur ML, Pallela VR, Consigny PM, Rao PS, Vessileva-Belnikolovska D, Shi R. Imaging vascular thrombosis with 99mTc-labeled fibrin alpha-chain peptide. J Nucl Med. 2000 Jan; 41(1):161-8. PMID: 10647619.
      Citations:    
    92. Thakur ML, Marcus CS, Saeed S, Pallela V, Minami C, Diggles L, Le Pham H, Ahdoot R, Kalinowski EA. 99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans. J Nucl Med. 2000 Jan; 41(1):107-10. PMID: 10647612.
      Citations:    
    93. Thakur ML, Marcus CS, Saeed S, Pallela V, Minami C, Diggles L, Pham HL, Ahdoot R, Kalinowski EA, Moody T. Imaging tumors in humans with Tc-99m-VIP. Ann N Y Acad Sci. 2000; 921:37-44. PMID: 11193855.
      Citations:    
    94. Mozley PD, Thakur ML, Alavi A, Smith T, Barraclough ED, Wilding P, Rhodes BA, Patel M, Mathur A, Li P. Effects of a 99mTc-labeled murine immunoglobulin M antibody to CD15 antigens on human granulocyte membranes in healthy volunteers. J Nucl Med. 1999 Dec; 40(12):2107-14. PMID: 10616893.
      Citations:    
    95. Mozley PD, Stubbs JB, Dresel SH, Barraclough ED, Smith T, Patel M, Finkelman C, Sparks RB, Thakur ML, Mathur A, Alavi A. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes. J Nucl Med. 1999 Apr; 40(4):625-30. PMID: 10210221.
      Citations:    
    96. Weiner RE, Thakur ML. Imaging infection/inflammations. Pathophysiologic basis and radiopharmaceuticals. Q J Nucl Med. 1999 Mar; 43(1):2-8. PMID: 10230276.
      Citations:    
    97. Pallela VR, Thakur ML, Consigny PM, Rao PS, Vasileva-Belnikolavska D, Shi R. Imaging thromboembolism with Tc-99m-labeled thrombospondin receptor analogs TP-1201 and TP-1300. Thromb Res. 1999 Feb 15; 93(4):191-202. PMID: 10064274.
      Citations:    
    98. Thakur ML, Li J, Kim SM, Zhang JJ, Andrews D. Targeting tumors with iodine-123 labeled deoxyuridine: distribution and DNA binding. Cancer Detect Prev. 1999; 23(1):72-7. PMID: 9892993.
      Citations:    
    99. John CS, Gulden ME, Li J, Bowen WD, McAfee JG, Thakur ML. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors. Nucl Med Biol. 1998 Apr; 25(3):189-94. PMID: 9620622.
      Citations:    
    100. Thakur ML. Thromboembolism: challenges for non-invasive diagnostic assessment. Nucl Med Commun. 1997 Apr; 18(4):386-7. PMID: 9170627.
      Citations:    
    101. Thakur ML, Kolan H, Li J, Wiaderkiewicz R, Pallela VR, Duggaraju R, Schally AV. Radiolabeled somatostatin analogs in prostate cancer. Nucl Med Biol. 1997 Jan; 24(1):105-13. PMID: 9080482.
      Citations:    
    102. Thakur ML, Marcus CS, Henneman P, Butler J, Sinow R, Diggles L, Minami C, Mason G, Klein S, Rhodes B. Imaging inflammatory diseases with neutrophil-specific technetium-99m-labeled monoclonal antibody anti-SSEA-1. J Nucl Med. 1996 Nov; 37(11):1789-95. PMID: 8917176.
      Citations:    
    103. Li J, Merton DA, Duggaraju R, Thakur ML. Augmenting of tumor uptake of anti-melanoma antibody MEM136: influence of interferon. Nucl Med Biol. 1996 Oct; 23(7):873-9. PMID: 8971854.
      Citations:    
    104. Kolan H, Li J, Thakur ML. Sandostatin labeled with 99mTc: in vitro stability, in vivo validity and comparison with 111In-DTPA-octreotide. Pept Res. 1996 May-Jun; 9(3):144-50. PMID: 8875594.
      Citations:    
    105. Li J, Duggaraju R, Maish DR, Thakur ML. Effect of interferon-alpha-2b on the enhancement of tumour uptake of 99Tcm-labelled monoclonal antibodies. Nucl Med Commun. 1996 Apr; 17(4):346-52. PMID: 8786872.
      Citations:    
    106. Thakur ML. Radiolabelled peptides: now and the future. Nucl Med Commun. 1995 Sep; 16(9):724-32. PMID: 7478404.
      Citations:    
    107. Thakur ML. Ascorbate plays a major role in labeling proteins with technetium-99m. J Nucl Med. 1994 Sep; 35(9):1566-8. PMID: 8071714.
      Citations:    
    108. John E, Thakur ML, Wilder S, Alauddin MM, Epstein AL. Technetium-99m-labeled monoclonal antibodies: influence of technetium-99m binding sites. J Nucl Med. 1994 May; 35(5):876-81. PMID: 8176476.
      Citations:    
    109. Varnum JM, Thakur ML, Schally AV, Jansen S, Mayo KH. Rhenium-labeled somatostatin analog RC-160. 1H NMR and computer modeling conformational analysis. J Biol Chem. 1994 Apr 29; 269(17):12583-8. PMID: 7909804.
      Citations:    
    110. Vinitski S, Thakur ML, Consigny PM, Mitchell DG, Mohamed FB, Ortega HV. Use of Ferrum in MRI of lung parenchyma and pulmonary embolism. Magn Reson Imaging. 1993; 11(4):499-508. PMID: 8316063.
      Citations:    
    111. Martin-Comin, Thakur ML. Proceedings of 6th Inter. Symposium on Radiolabeled Blood Elements. 1993.
    112. Thakur ML, DeFulvio J, Tong J, John E, McDevitt MR, Damjanov I. Evaluation of biological response modifiers in the enhancement of tumor uptake of technetium-99m labeled macromolecules. A preliminary report. J Immunol Methods. 1992 Aug 10; 152(2):209-16. PMID: 1500731.
      Citations:    
    113. Thakur ML, DeFulvio JD. Technetium-99m-labeled monoclonal antibodies for immunoscintigraphy. Simplified preparation and evaluation. J Immunol Methods. 1991 Mar 21; 137(2):217-24. PMID: 2013698.
      Citations:    
    114. Thakur ML, DeFulvio J, Richard MD, Park CH. Technetium-99m labeled monoclonal antibodies: evaluation of reducing agents. Int J Rad Appl Instrum B. 1991; 18(2):227-33. PMID: 2026499.
      Citations:    
    115. Thakur ML, DeFulvio J, Park CH, Damjanov A, Yaghsezian H, Jungkind D, Epstein A, McAfee JG. Technetium-99m-labeled proteins for imaging inflammatory foci. Int J Rad Appl Instrum B. 1991; 18(6):605-12. PMID: 1743984.
      Citations:    
    116. Thakur ML. Radiolabeled blood cells: perspectives and directions. Int J Rad Appl Instrum B. 1990; 17(1):41-7. PMID: 2407691.
      Citations:    
    117. Thakur ML. Immunoscintigraphic imaging of inflammatory lesions: preliminary findings and future possibilities. Semin Nucl Med. 1990 Jan; 20(1):92-8. PMID: 2404344.
      Citations:    
    118. Thakur ML, DeFulvio J. Radiolabeled antibodies specific for human blood elements. Prog Clin Biol Res. 1990; 355:281-92. PMID: 2281107.
      Citations:    
    119. Thakur ML, Lee J, Defulvio J, Richard MD, Park CH. Human neutrophils: evaluation of adherence, chemotaxis and phagocytosis, following interaction with radiolabeled antibodies. Nucl Med Commun. 1990 Jan; 11(1):37-43. PMID: 1971094.
      Citations:    
    120. Sinzinger H and Thakur ML. Radiolabeled cellular blood elements. 1990.
    121. Thakur ML, Richard MD, White FW. Monoclonal antibodies as agents for selective radiolabeling of human neutrophils. J Nucl Med. 1988 Nov; 29(11):1817-25. PMID: 3141596.
      Citations:    
    122. Zoghbi SS, Thakur ML, Sostman HD, Greenspan RH, Gottschalk A. Indium-111-oxinate labeled swine platelets and their survival in vivo. Lab Anim Sci. 1988 Aug; 38(4):444-7. PMID: 3141679.
      Citations:    
    123. Thakur ML, Leeper DB, Rowley R, Park CH. Radioiodinated rhodamine-123: preparation and preliminary evaluation as an agent for tumor scintigraphy. Int J Rad Appl Instrum B. 1988; 15(5):517-24. PMID: 3254874.
      Citations:    
    124. Thakur ML. Radiolabeled cellular blood elements pathophysiology, techniques and scintigraphic applications. 1985.
    125. Thakur ML, Gottschalk A. Indium111 labeled neutrophils, platelets and lymphocytes. 1980.
    126. Thakur ML. Novel use of a radiolabeled antibody, against stage specific embryonic antigen for the detection of occult abscesses in mammals.
    127. Thakur ML. Blood Agent.
    Thakur's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (295)
    Explore
    _
    Co-Authors (25)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _